<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1997-11-01" modified="2020-10-07" version="214">
<accession>Q12778</accession>
<accession>O43523</accession>
<accession>Q5VYC7</accession>
<accession>Q6NSK6</accession>
<name>FOXO1_HUMAN</name>
<protein>
<recommendedName>
<fullName>Forkhead box protein O1</fullName>
</recommendedName>
<alternativeName>
<fullName>Forkhead box protein O1A</fullName>
</alternativeName>
<alternativeName>
<fullName>Forkhead in rhabdomyosarcoma</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">FOXO1</name>
<name type="synonym">FKHR</name>
<name type="synonym">FOXO1A</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1993" name="Nat. Genet." volume="5" first="230" last="235">
<title>Fusion of a fork head domain gene to PAX3 in the solid tumour alveolar rhabdomyosarcoma.</title>
<authorList>
<person name="Galili N."/>
<person name="Davis R.J."/>
<person name="Fredericks W.J."/>
<person name="Mukhopadhyay S."/>
<person name="Rauscher F.J. III"/>
<person name="Emanuel B.S."/>
<person name="Rovera G."/>
<person name="Barr F.G."/>
</authorList>
<dbReference type="PubMed" id="8275086"/>
<dbReference type="DOI" id="10.1038/ng1193-230"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>CHROMOSOMAL TRANSLOCATION WITH PAX3</scope>
</reference>
<reference key="2">
<citation type="journal article" date="1998" name="Genomics" volume="47" first="187" last="199">
<title>Cloning and characterization of three human forkhead genes that comprise an FKHR-like gene subfamily.</title>
<authorList>
<person name="Anderson M.J."/>
<person name="Viars C.S."/>
<person name="Czekay S."/>
<person name="Cavenee W.K."/>
<person name="Arden K.C."/>
</authorList>
<dbReference type="PubMed" id="9479491"/>
<dbReference type="DOI" id="10.1006/geno.1997.5122"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>TISSUE SPECIFICITY</scope>
<source>
<tissue>Rhabdomyosarcoma</tissue>
</source>
</reference>
<reference key="3">
<citation type="submission" date="2003-05" db="EMBL/GenBank/DDBJ databases">
<title>Cloning of human full-length CDSs in BD Creator(TM) system donor vector.</title>
<authorList>
<person name="Kalnine N."/>
<person name="Chen X."/>
<person name="Rolfs A."/>
<person name="Halleck A."/>
<person name="Hines L."/>
<person name="Eisenstein S."/>
<person name="Koundinya M."/>
<person name="Raphael J."/>
<person name="Moreira D."/>
<person name="Kelley T."/>
<person name="LaBaer J."/>
<person name="Lin Y."/>
<person name="Phelan M."/>
<person name="Farmer A."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
</reference>
<reference key="4">
<citation type="journal article" date="2004" name="Nature" volume="428" first="522" last="528">
<title>The DNA sequence and analysis of human chromosome 13.</title>
<authorList>
<person name="Dunham A."/>
<person name="Matthews L.H."/>
<person name="Burton J."/>
<person name="Ashurst J.L."/>
<person name="Howe K.L."/>
<person name="Ashcroft K.J."/>
<person name="Beare D.M."/>
<person name="Burford D.C."/>
<person name="Hunt S.E."/>
<person name="Griffiths-Jones S."/>
<person name="Jones M.C."/>
<person name="Keenan S.J."/>
<person name="Oliver K."/>
<person name="Scott C.E."/>
<person name="Ainscough R."/>
<person name="Almeida J.P."/>
<person name="Ambrose K.D."/>
<person name="Andrews D.T."/>
<person name="Ashwell R.I.S."/>
<person name="Babbage A.K."/>
<person name="Bagguley C.L."/>
<person name="Bailey J."/>
<person name="Bannerjee R."/>
<person name="Barlow K.F."/>
<person name="Bates K."/>
<person name="Beasley H."/>
<person name="Bird C.P."/>
<person name="Bray-Allen S."/>
<person name="Brown A.J."/>
<person name="Brown J.Y."/>
<person name="Burrill W."/>
<person name="Carder C."/>
<person name="Carter N.P."/>
<person name="Chapman J.C."/>
<person name="Clamp M.E."/>
<person name="Clark S.Y."/>
<person name="Clarke G."/>
<person name="Clee C.M."/>
<person name="Clegg S.C."/>
<person name="Cobley V."/>
<person name="Collins J.E."/>
<person name="Corby N."/>
<person name="Coville G.J."/>
<person name="Deloukas P."/>
<person name="Dhami P."/>
<person name="Dunham I."/>
<person name="Dunn M."/>
<person name="Earthrowl M.E."/>
<person name="Ellington A.G."/>
<person name="Faulkner L."/>
<person name="Frankish A.G."/>
<person name="Frankland J."/>
<person name="French L."/>
<person name="Garner P."/>
<person name="Garnett J."/>
<person name="Gilbert J.G.R."/>
<person name="Gilson C.J."/>
<person name="Ghori J."/>
<person name="Grafham D.V."/>
<person name="Gribble S.M."/>
<person name="Griffiths C."/>
<person name="Hall R.E."/>
<person name="Hammond S."/>
<person name="Harley J.L."/>
<person name="Hart E.A."/>
<person name="Heath P.D."/>
<person name="Howden P.J."/>
<person name="Huckle E.J."/>
<person name="Hunt P.J."/>
<person name="Hunt A.R."/>
<person name="Johnson C."/>
<person name="Johnson D."/>
<person name="Kay M."/>
<person name="Kimberley A.M."/>
<person name="King A."/>
<person name="Laird G.K."/>
<person name="Langford C.J."/>
<person name="Lawlor S."/>
<person name="Leongamornlert D.A."/>
<person name="Lloyd D.M."/>
<person name="Lloyd C."/>
<person name="Loveland J.E."/>
<person name="Lovell J."/>
<person name="Martin S."/>
<person name="Mashreghi-Mohammadi M."/>
<person name="McLaren S.J."/>
<person name="McMurray A."/>
<person name="Milne S."/>
<person name="Moore M.J.F."/>
<person name="Nickerson T."/>
<person name="Palmer S.A."/>
<person name="Pearce A.V."/>
<person name="Peck A.I."/>
<person name="Pelan S."/>
<person name="Phillimore B."/>
<person name="Porter K.M."/>
<person name="Rice C.M."/>
<person name="Searle S."/>
<person name="Sehra H.K."/>
<person name="Shownkeen R."/>
<person name="Skuce C.D."/>
<person name="Smith M."/>
<person name="Steward C.A."/>
<person name="Sycamore N."/>
<person name="Tester J."/>
<person name="Thomas D.W."/>
<person name="Tracey A."/>
<person name="Tromans A."/>
<person name="Tubby B."/>
<person name="Wall M."/>
<person name="Wallis J.M."/>
<person name="West A.P."/>
<person name="Whitehead S.L."/>
<person name="Willey D.L."/>
<person name="Wilming L."/>
<person name="Wray P.W."/>
<person name="Wright M.W."/>
<person name="Young L."/>
<person name="Coulson A."/>
<person name="Durbin R.M."/>
<person name="Hubbard T."/>
<person name="Sulston J.E."/>
<person name="Beck S."/>
<person name="Bentley D.R."/>
<person name="Rogers J."/>
<person name="Ross M.T."/>
</authorList>
<dbReference type="PubMed" id="15057823"/>
<dbReference type="DOI" id="10.1038/nature02379"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="5">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<source>
<tissue>Lymph</tissue>
<tissue>Placenta</tissue>
</source>
</reference>
<reference key="6">
<citation type="journal article" date="1994" name="Cancer Res." volume="54" first="2869" last="2872">
<title>Fusion of PAX7 to FKHR by the variant t(1;13)(p36;q14) translocation in alveolar rhabdomyosarcoma.</title>
<authorList>
<person name="Davis R.J."/>
<person name="D'Cruz C.M."/>
<person name="Lovell M.A."/>
<person name="Biegel J.A."/>
<person name="Barr F.G."/>
</authorList>
<dbReference type="PubMed" id="8187070"/>
</citation>
<scope>CHROMOSOMAL TRANSLOCATION WITH PAX7</scope>
</reference>
<reference key="7">
<citation type="journal article" date="1999" name="J. Biol. Chem." volume="274" first="17179" last="17183">
<title>Phosphorylation of the transcription factor forkhead family member FKHR by protein kinase B.</title>
<authorList>
<person name="Rena G."/>
<person name="Guo S."/>
<person name="Cichy S.C."/>
<person name="Unterman T.G."/>
<person name="Cohen P."/>
</authorList>
<dbReference type="PubMed" id="10358075"/>
<dbReference type="DOI" id="10.1074/jbc.274.24.17179"/>
</citation>
<scope>PHOSPHORYLATION AT THR-24; SER-256 AND SER-319</scope>
</reference>
<reference key="8">
<citation type="journal article" date="1999" name="J. Biol. Chem." volume="274" first="17184" last="17192">
<title>Phosphorylation of serine 256 by protein kinase B disrupts transactivation by FKHR and mediates effects of insulin on insulin-like growth factor-binding protein-1 promoter activity through a conserved insulin response sequence.</title>
<authorList>
<person name="Guo S."/>
<person name="Rena G."/>
<person name="Cichy S."/>
<person name="He X."/>
<person name="Cohen P."/>
<person name="Unterman T."/>
</authorList>
<dbReference type="PubMed" id="10358076"/>
<dbReference type="DOI" id="10.1074/jbc.274.24.17184"/>
</citation>
<scope>DNA-BINDING</scope>
<scope>PHOSPHORYLATION AT SER-256</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2001" name="Biochem. J." volume="355" first="597" last="607">
<title>The kinase DYRK1A phosphorylates the transcription factor FKHR at Ser329 in vitro, a novel in vivo phosphorylation site.</title>
<authorList>
<person name="Woods Y.L."/>
<person name="Rena G."/>
<person name="Morrice N."/>
<person name="Barthel A."/>
<person name="Becker W."/>
<person name="Guo S."/>
<person name="Unterman T.G."/>
<person name="Cohen P."/>
</authorList>
<dbReference type="PubMed" id="11311120"/>
<dbReference type="DOI" id="10.1042/bj3550597"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
<scope>PHOSPHORYLATION AT SER-329</scope>
<scope>MUTAGENESIS OF SER-329</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2001" name="Biochem. J." volume="354" first="605" last="612">
<title>Roles of the forkhead in rhabdomyosarcoma (FKHR) phosphorylation sites in regulating 14-3-3 binding, transactivation and nuclear targetting.</title>
<authorList>
<person name="Rena G."/>
<person name="Prescott A.R."/>
<person name="Guo S."/>
<person name="Cohen P."/>
<person name="Unterman T.G."/>
</authorList>
<dbReference type="PubMed" id="11237865"/>
<dbReference type="DOI" id="10.1042/0264-6021:3540605"/>
</citation>
<scope>INTERACTION WITH YWHAG AND YWHAZ</scope>
<scope>PHOSPHORYLATION AT THR-24; SER-256 AND SER-319</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>MUTAGENESIS OF THR-24; SER-256 AND SER-319</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2002" name="EMBO J." volume="21" first="2263" last="2271">
<title>Two novel phosphorylation sites on FKHR that are critical for its nuclear exclusion.</title>
<authorList>
<person name="Rena G."/>
<person name="Woods Y.L."/>
<person name="Prescott A.R."/>
<person name="Peggie M."/>
<person name="Unterman T.G."/>
<person name="Williams M.R."/>
<person name="Cohen P."/>
</authorList>
<dbReference type="PubMed" id="11980723"/>
<dbReference type="DOI" id="10.1093/emboj/21.9.2263"/>
</citation>
<scope>PHOSPHORYLATION AT THR-24; SER-256; SER-319; SER-322; SER-325 AND SER-329</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2002" name="J. Biol. Chem." volume="277" first="45276" last="45284">
<title>Phosphorylation of serine 256 suppresses transactivation by FKHR (FOXO1) by multiple mechanisms. Direct and indirect effects on nuclear/cytoplasmic shuttling and DNA binding.</title>
<authorList>
<person name="Zhang X."/>
<person name="Gan L."/>
<person name="Pan H."/>
<person name="Guo S."/>
<person name="He X."/>
<person name="Olson S.T."/>
<person name="Mesecar A."/>
<person name="Adam S."/>
<person name="Unterman T.G."/>
</authorList>
<dbReference type="PubMed" id="12228231"/>
<dbReference type="DOI" id="10.1074/jbc.m208063200"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>MUTAGENESIS OF THR-24; SER-256 AND SER-319</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2004" name="Proc. Natl. Acad. Sci. U.S.A." volume="101" first="10042" last="10047">
<title>Silent information regulator 2 potentiates Foxo1-mediated transcription through its deacetylase activity.</title>
<authorList>
<person name="Daitoku H."/>
<person name="Hatta M."/>
<person name="Matsuzaki H."/>
<person name="Aratani S."/>
<person name="Ohshima T."/>
<person name="Miyagishi M."/>
<person name="Nakajima T."/>
<person name="Fukamizu A."/>
</authorList>
<dbReference type="PubMed" id="15220471"/>
<dbReference type="DOI" id="10.1073/pnas.0400593101"/>
</citation>
<scope>INTERACTION WITH CREBBP AND SIRT1</scope>
<scope>ACETYLATION</scope>
<scope>DEACETYLATION</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2005" name="Mol. Endocrinol." volume="19" first="2283" last="2298">
<title>The coactivator p300 directly acetylates the forkhead transcription factor Foxo1 and stimulates Foxo1-induced transcription.</title>
<authorList>
<person name="Perrot V."/>
<person name="Rechler M.M."/>
</authorList>
<dbReference type="PubMed" id="15890677"/>
<dbReference type="DOI" id="10.1210/me.2004-0292"/>
</citation>
<scope>INTERACTION WITH EP300</scope>
<scope>ACETYLATION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>PHOSPHORYLATION</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2005" name="Proc. Natl. Acad. Sci. U.S.A." volume="102" first="1649" last="1654">
<title>Skp2 inhibits FOXO1 in tumor suppression through ubiquitin-mediated degradation.</title>
<authorList>
<person name="Huang H."/>
<person name="Regan K.M."/>
<person name="Wang F."/>
<person name="Wang D."/>
<person name="Smith D.I."/>
<person name="van Deursen J.M."/>
<person name="Tindall D.J."/>
</authorList>
<dbReference type="PubMed" id="15668399"/>
<dbReference type="DOI" id="10.1073/pnas.0406789102"/>
</citation>
<scope>INTERACTION WITH SKP2</scope>
<scope>UBIQUITINATION</scope>
<scope>MUTAGENESIS OF SER-256</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2008" name="Mol. Cell" volume="32" first="221" last="231">
<title>Arginine methylation of FOXO transcription factors inhibits their phosphorylation by Akt.</title>
<authorList>
<person name="Yamagata K."/>
<person name="Daitoku H."/>
<person name="Takahashi Y."/>
<person name="Namiki K."/>
<person name="Hisatake K."/>
<person name="Kako K."/>
<person name="Mukai H."/>
<person name="Kasuya Y."/>
<person name="Fukamizu A."/>
</authorList>
<dbReference type="PubMed" id="18951090"/>
<dbReference type="DOI" id="10.1016/j.molcel.2008.09.013"/>
</citation>
<scope>INTERACTION WITH PRMT1</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-287</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="18">
<citation type="journal article" date="2008" name="Science" volume="319" first="1665" last="1668">
<title>Activation of FOXO1 by Cdk1 in cycling cells and postmitotic neurons.</title>
<authorList>
<person name="Yuan Z."/>
<person name="Becker E.B.E."/>
<person name="Merlo P."/>
<person name="Yamada T."/>
<person name="DiBacco S."/>
<person name="Konishi Y."/>
<person name="Schaefer E.M."/>
<person name="Bonni A."/>
</authorList>
<dbReference type="PubMed" id="18356527"/>
<dbReference type="DOI" id="10.1126/science.1152337"/>
</citation>
<scope>FUNCTION</scope>
<scope>PHOSPHORYLATION AT SER-249 BY CDK1</scope>
<scope>INTERACTION WITH CDK1 AND 14-3-3 PROTEINS</scope>
<scope>MUTAGENESIS OF SER-249</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2009" name="Anal. Chem." volume="81" first="4493" last="4501">
<title>Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach.</title>
<authorList>
<person name="Gauci S."/>
<person name="Helbig A.O."/>
<person name="Slijper M."/>
<person name="Krijgsveld J."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="19413330"/>
<dbReference type="DOI" id="10.1021/ac9004309"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2009" name="J. Biol. Chem." volume="284" first="11285" last="11292">
<title>Regulation of neuronal cell death by MST1-FOXO1 signaling.</title>
<authorList>
<person name="Yuan Z."/>
<person name="Lehtinen M.K."/>
<person name="Merlo P."/>
<person name="Villen J."/>
<person name="Gygi S."/>
<person name="Bonni A."/>
</authorList>
<dbReference type="PubMed" id="19221179"/>
<dbReference type="DOI" id="10.1074/jbc.m900461200"/>
</citation>
<scope>PHOSPHORYLATION AT SER-212</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>FUNCTION</scope>
<scope>MUTAGENESIS OF SER-212</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2010" name="Nat. Cell Biol." volume="12" first="665" last="675">
<title>Cytosolic FoxO1 is essential for the induction of autophagy and tumour suppressor activity.</title>
<authorList>
<person name="Zhao Y."/>
<person name="Yang J."/>
<person name="Liao W."/>
<person name="Liu X."/>
<person name="Zhang H."/>
<person name="Wang S."/>
<person name="Wang D."/>
<person name="Feng J."/>
<person name="Yu L."/>
<person name="Zhu W.G."/>
</authorList>
<dbReference type="PubMed" id="20543840"/>
<dbReference type="DOI" id="10.1038/ncb2069"/>
</citation>
<scope>ACETYLATION AT LYS-262; LYS-265 AND LYS-274</scope>
<scope>DEACETYLATION BY SIRT2</scope>
<scope>FUNCTION IN AUTOPHAGY</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH SIRT2 AND ATG7</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2010" name="PLoS ONE" volume="5" first="E11786" last="E11786">
<title>KRIT1 regulates the homeostasis of intracellular reactive oxygen species.</title>
<authorList>
<person name="Goitre L."/>
<person name="Balzac F."/>
<person name="Degani S."/>
<person name="Degan P."/>
<person name="Marchi S."/>
<person name="Pinton P."/>
<person name="Retta S.F."/>
</authorList>
<dbReference type="PubMed" id="20668652"/>
<dbReference type="DOI" id="10.1371/journal.pone.0011786"/>
</citation>
<scope>INDUCTION</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
<title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Vermeulen M."/>
<person name="Santamaria A."/>
<person name="Kumar C."/>
<person name="Miller M.L."/>
<person name="Jensen L.J."/>
<person name="Gnad F."/>
<person name="Cox J."/>
<person name="Jensen T.S."/>
<person name="Nigg E.A."/>
<person name="Brunak S."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="20068231"/>
<dbReference type="DOI" id="10.1126/scisignal.2000475"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-287</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="24">
<citation type="journal article" date="2011" name="Cancer Res." volume="71" first="946" last="954">
<title>Hippo/Mst1 stimulates transcription of the proapoptotic mediator NOXA in a FoxO1-dependent manner.</title>
<authorList>
<person name="Valis K."/>
<person name="Prochazka L."/>
<person name="Boura E."/>
<person name="Chladova J."/>
<person name="Obsil T."/>
<person name="Rohlena J."/>
<person name="Truksa J."/>
<person name="Dong L.F."/>
<person name="Ralph S.J."/>
<person name="Neuzil J."/>
</authorList>
<dbReference type="PubMed" id="21245099"/>
<dbReference type="DOI" id="10.1158/0008-5472.can-10-2203"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>PHOSPHORYLATION AT SER-212</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2011" name="Sci. Signal." volume="4" first="RS3" last="RS3">
<title>System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.</title>
<authorList>
<person name="Rigbolt K.T."/>
<person name="Prokhorova T.A."/>
<person name="Akimov V."/>
<person name="Henningsen J."/>
<person name="Johansen P.T."/>
<person name="Kratchmarova I."/>
<person name="Kassem M."/>
<person name="Mann M."/>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
</authorList>
<dbReference type="PubMed" id="21406692"/>
<dbReference type="DOI" id="10.1126/scisignal.2001570"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-287</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="27">
<citation type="journal article" date="2019" name="Cell. Signal." volume="61" first="57" last="65">
<title>Cyclophilin A-FoxO1 signaling pathway in endothelial cell apoptosis.</title>
<authorList>
<person name="Xie Y."/>
<person name="Li X."/>
<person name="Ge J."/>
</authorList>
<dbReference type="PubMed" id="31063815"/>
<dbReference type="DOI" id="10.1016/j.cellsig.2019.04.014"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>PHOSPHORYLATION AT SER-256</scope>
<scope>DEPHOSPHORYLATION AT SER-256</scope>
<scope>INTERACTION WITH PPIA</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2008" name="Structure" volume="16" first="1407" last="1416">
<title>Structural basis for DNA recognition by FoxO1 and its regulation by posttranslational modification.</title>
<authorList>
<person name="Brent M.M."/>
<person name="Anand R."/>
<person name="Marmorstein R."/>
</authorList>
<dbReference type="PubMed" id="18786403"/>
<dbReference type="DOI" id="10.1016/j.str.2008.06.013"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) OF 151-266</scope>
<scope>DNA-BINDING</scope>
<scope>PHOSPHORYLATION AT SER-212; SER-218; SER-234 AND SER-235</scope>
<scope>ACETYLATION</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
<scope>MUTAGENESIS OF SER-249</scope>
</reference>
<comment type="function">
<text evidence="7 8 9 12 16 17 19 20 23 24 26 27">Transcription factor that is the main target of insulin signaling and regulates metabolic homeostasis in response to oxidative stress (PubMed:10358076, PubMed:12228231, PubMed:15220471, PubMed:15890677, PubMed:18356527, PubMed:19221179, PubMed:20543840, PubMed:21245099). Binds to the insulin response element (IRE) with consensus sequence 5'-TT[G/A]TTTTG-3' and the related Daf-16 family binding element (DBE) with consensus sequence 5'-TT[G/A]TTTAC-3' (PubMed:10358076). Activity suppressed by insulin (PubMed:10358076). Main regulator of redox balance and osteoblast numbers and controls bone mass (By similarity). Orchestrates the endocrine function of the skeleton in regulating glucose metabolism (By similarity). lso acts as a key regulator of chondrogenic commitment of skeletal progenitor cells in response to lipid availability: when lipids levels are low, translocates to the nucleus and promotes expression of SOX9, which induces chondrogenic commitment and suppresses fatty acid oxidation (By similarity). Acts synergistically with ATF4 to suppress osteocalcin/BGLAP activity, increasing glucose levels and triggering glucose intolerance and insulin insensitivity (By similarity). Also suppresses the transcriptional activity of RUNX2, an upstream activator of osteocalcin/BGLAP (By similarity). In hepatocytes, promotes gluconeogenesis by acting together with PPARGC1A and CEBPA to activate the expression of genes such as IGFBP1, G6PC and PCK1 (By similarity). Important regulator of cell death acting downstream of CDK1, PKB/AKT1 and STK4/MST1 (PubMed:18356527, PubMed:19221179). Promotes neural cell death (PubMed:18356527). Mediates insulin action on adipose tissue (By similarity). Regulates the expression of adipogenic genes such as PPARG during preadipocyte differentiation and, adipocyte size and adipose tissue-specific gene expression in response to excessive calorie intake (By similarity). Regulates the transcriptional activity of GADD45A and repair of nitric oxide-damaged DNA in beta-cells (By similarity). Required for the autophagic cell death induction in response to starvation or oxidative stress in a transcription-independent manner (PubMed:20543840). Mediates the function of MLIP in cardiomyocytes hypertrophy and cardiac remodeling (By similarity). Regulates endothelial cell (EC) viability and apoptosis in a PPIA/CYPA-dependent manner via transcription of CCL2 and BCL2L11 which are involved in EC chemotaxis and apoptosis (PubMed:31063815).</text>
</comment>
<comment type="subunit">
<text evidence="9 13 17 18 19 20 22 24 27">Interacts with LRPPRC. Interacts with RUNX2; the interaction inhibits RUNX2 transcriptional activity and mediates the IGF1/insulin-dependent BGLAP expression in osteoblasts Interacts with PPP2R1A; the interaction regulates the dephosphorylation of FOXO1 at Thr-24 and Ser-256 leading to its nuclear import. Interacts (acetylated form) with PPARG. Interacts with XBP1 isoform 2; this interaction is direct and leads to FOXO1 ubiquitination and degradation via the proteasome pathway (By similarity). Interacts with NLK. Interacts with SIRT1; the interaction results in the deacetylation of FOXO1 leading to activation of FOXO1-mediated transcription of genes involved in DNA repair and stress resistance. Binds to CDK1. Interacts with the 14-3-3 proteins, YWHAG and YWHAZ; the interactions require insulin-stimulated phosphorylation on Thr-24, promote nuclear exit and loss of transcriptional activity. Interacts with SKP2; the interaction ubiquitinates FOXO1 leading to its proteosomal degradation. The interaction requires the presence of KRIT1. Interacts (via the C-terminal half) with ATF4 (via its DNA-binding domain); the interaction occurs in osteoblasts, regulates glucose homeostasis via suppression of beta-cell proliferation and subsequent decrease in insulin production. Interacts with PRMT1; the interaction methylates FOXO1, prevents PKB/AKT1 phosphorylation and retains FOXO1 in the nucleus. Interacts with EP300 and CREBBP; the interactions acetylate FOXO1. Interacts with SIRT2; the interaction is disrupted in response to oxidative stress or serum deprivation, leading to increased level of acetylated FOXO1, which promotes stress-induced autophagy by stimulating E1-like activating enzyme ATG7. Interacts (acetylated form) with ATG7; the interaction is increased in response to oxidative stress or serum deprivation and promotes the autophagic process leading to cell death. Interacts (via the Fork-head domain) with CEBPA; the interaction increases when FOXO1 is deacetylated. Interacts with WDFY2. Forms a complex with WDFY2 and AKT1 (By similarity). Interacts with CRY1 (By similarity). Interacts with PPIA/CYPA; the interaction promotes FOXO1 dephosphorylation, nuclear accumulation and transcriptional activity (PubMed:31063815).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1108782">
<id>Q12778</id>
</interactant>
<interactant intactId="EBI-296087">
<id>P31749</id>
<label>AKT1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1108782">
<id>Q12778</id>
</interactant>
<interactant intactId="EBI-495332">
<id>P14635</id>
<label>CCNB1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1108782">
<id>Q12778</id>
</interactant>
<interactant intactId="EBI-444308">
<id>P06493</id>
<label>CDK1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1108782">
<id>Q12778</id>
</interactant>
<interactant intactId="EBI-81215">
<id>Q92793</id>
<label>CREBBP</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1108782">
<id>Q12778</id>
</interactant>
<interactant intactId="EBI-78473">
<id>P03372</id>
<label>ESR1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1108782">
<id>Q12778</id>
</interactant>
<interactant intactId="EBI-21403286">
<id>P14921-3</id>
<label>ETS1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1108782">
<id>Q12778</id>
</interactant>
<interactant intactId="EBI-701903">
<id>Q14192</id>
<label>FHL2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>8</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1108782">
<id>Q12778</id>
</interactant>
<interactant intactId="EBI-1053182">
<id>Q01105</id>
<label>SET</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1108782">
<id>Q12778</id>
</interactant>
<interactant intactId="EBI-1802965">
<id>Q96EB6</id>
<label>SIRT1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1108782">
<id>Q12778</id>
</interactant>
<interactant intactId="EBI-347088">
<id>P63104</id>
<label>YWHAZ</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1108782">
<id>Q12778</id>
</interactant>
<interactant intactId="EBI-1802585">
<id>Q923E4</id>
<label>Sirt1</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="13 14 16 23 24 26 27">Cytoplasm</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="14 16 24 27">Nucleus</location>
</subcellularLocation>
<text evidence="9 13 14 16 20 23 24 26 27">Shuttles between the cytoplasm and nucleus. Largely nuclear in unstimulated cells (PubMed:11311120, PubMed:12228231, PubMed:19221179, PubMed:21245099, PubMed:20543840). In osteoblasts, colocalizes with ATF4 and RUNX2 in the nucleus (By similarity). Serum deprivation increases localization to the nucleus, leading to activate expression of SOX9 and subsequent chondrogenesis (By similarity). Insulin-induced phosphorylation at Ser-256 by PKB/AKT1 leads, via stimulation of Thr-24 phosphorylation, to binding of 14-3-3 proteins and nuclear export to the cytoplasm where it is degraded by the ubiquitin-proteosomal pathway (PubMed:11237865, PubMed:12228231). Phosphorylation at Ser-249 by CDK1 disrupts binding of 14-3-3 proteins and promotes nuclear accumulation (PubMed:18356527). Phosphorylation by NLK results in nuclear export (By similarity). Translocates to the nucleus upon oxidative stress-induced phosphorylation at Ser-212 by STK4/MST1 (PubMed:19221179, PubMed:21245099). SGK1-mediated phosphorylation also results in nuclear translocation (By similarity). Retained in the nucleus under stress stimuli including oxidative stress, nutrient deprivation or nitric oxide (By similarity). Retained in the nucleus on methylation (By similarity). PPIA/CYPA stimulates its nuclear accumulation (PubMed:31063815).</text>
</comment>
<comment type="tissue specificity">
<text evidence="28">Ubiquitous.</text>
</comment>
<comment type="induction">
<text evidence="25">Expression is regulated by KRIT1. Levels of expression also regulated by FOXC1 which binds to a conserved element in the FOXO1 promoter.</text>
</comment>
<comment type="PTM">
<text evidence="9 11 12 13 14 15 20 21 23 26 27">Phosphorylation by NLK promotes nuclear export and inhibits the transcriptional activity. In response to growth factors, phosphorylation on Thr-24, Ser-256 and Ser-322 by PKB/AKT1 promotes nuclear export and inactivation of transactivational activity. Phosphorylation on Thr-24 is required for binding 14-3-3 proteins. Phosphorylation of Ser-256 decreases DNA-binding activity and promotes the phosphorylation of Thr-24 and Ser-319, permitting phosphorylation of Ser-322 and Ser-325, probably by CDK1, leading to nuclear exclusion and loss of function. Stress signals, such as response to oxygen or nitric oxide, attenuate the PKB/AKT1-mediated phosphorylation leading to nuclear retention. Phosphorylation of Ser-329 is independent of IGF1 and leads to reduced function. Dephosphorylated on Thr-24 and Ser-256 by PP2A in beta-cells under oxidative stress leading to nuclear retention (By similarity). Phosphorylation of Ser-249 by CDK1 disrupts binding of 14-3-3 proteins leading to nuclear accumulation and has no effect on DNA-binding nor transcriptional activity. Phosphorylation by STK4/MST1 on Ser-212, upon oxidative stress, inhibits binding to 14-3-3 proteins and nuclear export. PPIA/CYPA promotes its dephosphorylation on Ser-256 (PubMed:31063815).</text>
</comment>
<comment type="PTM">
<text evidence="24">Acetylated. Acetylation at Lys-262, Lys-265 and Lys-274 are necessary for autophagic cell death induction. Deacetylated by SIRT2 in response to oxidative stress or serum deprivation, thereby negatively regulating FOXO1-mediated autophagic cell death.</text>
</comment>
<comment type="PTM">
<text evidence="18">Ubiquitinated by SKP2. Ubiquitination leads to proteasomal degradation.</text>
</comment>
<comment type="PTM">
<text evidence="6">Methylation inhibits AKT1-mediated phosphorylation at Ser-256 and is increased by oxidative stress.</text>
</comment>
<comment type="PTM">
<text evidence="11 12 13 15">Once in the nucleus, acetylated by CREBBP/EP300. Acetylation diminishes the interaction with target DNA and attenuates the transcriptional activity. It increases the phosphorylation at Ser-256. Deacetylation by SIRT1 results in reactivation of the transcriptional activity. Oxidative stress by hydrogen peroxide treatment appears to promote deacetylation and uncoupling of insulin-induced phosphorylation. By contrast, resveratrol acts independently of acetylation.</text>
</comment>
<comment type="disease">
<disease id="DI-02699">
<name>Rhabdomyosarcoma 2</name>
<acronym>RMS2</acronym>
<description>A form of rhabdomyosarcoma, a highly malignant tumor of striated muscle derived from primitive mesenchymal cells and exhibiting differentiation along rhabdomyoblastic lines. Rhabdomyosarcoma is one of the most frequently occurring soft tissue sarcomas and the most common in children. It occurs in four forms: alveolar, pleomorphic, embryonal and botryoidal rhabdomyosarcomas.</description>
<dbReference type="MIM" id="268220"/>
</disease>
<text>The gene represented in this entry may be involved in disease pathogenesis. Chromosomal aberrations involving FOXO1 are found in rhabdomyosarcoma. Translocation (2;13)(q35;q14) with PAX3 and translocation t(1;13)(p36;q14) with PAX7. The resulting protein is a transcriptional activator.</text>
</comment>
<comment type="online information" name="Atlas of Genetics and Cytogenetics in Oncology and Haematology">
<link uri="http://atlasgeneticsoncology.org/Genes/FOXO1ID83ch13q14.html"/>
</comment>
<dbReference type="EMBL" id="U02310">
<property type="protein sequence ID" value="AAA03629.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF032885">
<property type="protein sequence ID" value="AAC39591.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BT007455">
<property type="protein sequence ID" value="AAP36123.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AL355132">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL133318">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC021981">
<property type="protein sequence ID" value="AAH21981.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC070065">
<property type="protein sequence ID" value="AAH70065.3"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS9371.1"/>
<dbReference type="PIR" id="S40521">
<property type="entry name" value="S40521"/>
</dbReference>
<dbReference type="RefSeq" id="NP_002006.2">
<property type="nucleotide sequence ID" value="NM_002015.3"/>
</dbReference>
<dbReference type="PDB" id="3CO6">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.10"/>
<property type="chains" value="C=151-249"/>
</dbReference>
<dbReference type="PDB" id="3CO7">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.91"/>
<property type="chains" value="C/F=151-266"/>
</dbReference>
<dbReference type="PDB" id="3COA">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.20"/>
<property type="chains" value="C/F=151-266"/>
</dbReference>
<dbReference type="PDB" id="4LG0">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.19"/>
<property type="chains" value="A=143-270"/>
</dbReference>
<dbReference type="PDB" id="5DUI">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.31"/>
<property type="chains" value="A/B=151-259"/>
</dbReference>
<dbReference type="PDB" id="6QVW">
<property type="method" value="NMR"/>
<property type="chains" value="A=159-272"/>
</dbReference>
<dbReference type="PDB" id="6QZR">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.30"/>
<property type="chains" value="J/M/N/O/P/R/T/U=19-29"/>
</dbReference>
<dbReference type="PDB" id="6QZS">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.90"/>
<property type="chains" value="C/P=251-262"/>
</dbReference>
<dbReference type="PDBsum" id="3CO6"/>
<dbReference type="PDBsum" id="3CO7"/>
<dbReference type="PDBsum" id="3COA"/>
<dbReference type="PDBsum" id="4LG0"/>
<dbReference type="PDBsum" id="5DUI"/>
<dbReference type="PDBsum" id="6QVW"/>
<dbReference type="PDBsum" id="6QZR"/>
<dbReference type="PDBsum" id="6QZS"/>
<dbReference type="SMR" id="Q12778"/>
<dbReference type="BioGRID" id="108597">
<property type="interactions" value="66"/>
</dbReference>
<dbReference type="CORUM" id="Q12778"/>
<dbReference type="DIP" id="DIP-35654N"/>
<dbReference type="IntAct" id="Q12778">
<property type="interactions" value="37"/>
</dbReference>
<dbReference type="MINT" id="Q12778"/>
<dbReference type="STRING" id="9606.ENSP00000368880"/>
<dbReference type="BindingDB" id="Q12778"/>
<dbReference type="ChEMBL" id="CHEMBL5294"/>
<dbReference type="GlyConnect" id="2844">
<property type="glycosylation" value="1 O-Linked glycan (4 sites)"/>
</dbReference>
<dbReference type="iPTMnet" id="Q12778"/>
<dbReference type="PhosphoSitePlus" id="Q12778"/>
<dbReference type="BioMuta" id="FOXO1"/>
<dbReference type="DMDM" id="116241368"/>
<dbReference type="CPTAC" id="CPTAC-1323"/>
<dbReference type="EPD" id="Q12778"/>
<dbReference type="jPOST" id="Q12778"/>
<dbReference type="MassIVE" id="Q12778"/>
<dbReference type="MaxQB" id="Q12778"/>
<dbReference type="PaxDb" id="Q12778"/>
<dbReference type="PeptideAtlas" id="Q12778"/>
<dbReference type="PRIDE" id="Q12778"/>
<dbReference type="ProteomicsDB" id="58922"/>
<dbReference type="Antibodypedia" id="645">
<property type="antibodies" value="2046 antibodies"/>
</dbReference>
<dbReference type="DNASU" id="2308"/>
<dbReference type="Ensembl" id="ENST00000379561">
<property type="protein sequence ID" value="ENSP00000368880"/>
<property type="gene ID" value="ENSG00000150907"/>
</dbReference>
<dbReference type="GeneID" id="2308"/>
<dbReference type="KEGG" id="hsa:2308"/>
<dbReference type="UCSC" id="uc001uxl.5">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="2308"/>
<dbReference type="DisGeNET" id="2308"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000150907.6"/>
<dbReference type="GeneCards" id="FOXO1"/>
<dbReference type="HGNC" id="HGNC:3819">
<property type="gene designation" value="FOXO1"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000150907">
<property type="expression patterns" value="Tissue enhanced (skeletal)"/>
</dbReference>
<dbReference type="MalaCards" id="FOXO1"/>
<dbReference type="MIM" id="136533">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="268220">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q12778"/>
<dbReference type="OpenTargets" id="ENSG00000150907"/>
<dbReference type="Orphanet" id="99756">
<property type="disease" value="Alveolar rhabdomyosarcoma"/>
</dbReference>
<dbReference type="PharmGKB" id="PA28237"/>
<dbReference type="eggNOG" id="KOG2294">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00940000161558"/>
<dbReference type="HOGENOM" id="CLU_023456_1_1_1"/>
<dbReference type="InParanoid" id="Q12778"/>
<dbReference type="KO" id="K07201"/>
<dbReference type="OMA" id="YSKWPGS"/>
<dbReference type="OrthoDB" id="1160384at2759"/>
<dbReference type="PhylomeDB" id="Q12778"/>
<dbReference type="TreeFam" id="TF315583"/>
<dbReference type="PathwayCommons" id="Q12778"/>
<dbReference type="Reactome" id="R-HSA-198693">
<property type="pathway name" value="AKT phosphorylates targets in the nucleus"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-210745">
<property type="pathway name" value="Regulation of gene expression in beta cells"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-211163">
<property type="pathway name" value="AKT-mediated inactivation of FOXO1A"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5674400">
<property type="pathway name" value="Constitutive Signaling by AKT1 E17K in Cancer"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5687128">
<property type="pathway name" value="MAPK6/MAPK4 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6785807">
<property type="pathway name" value="Interleukin-4 and Interleukin-13 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9614399">
<property type="pathway name" value="Regulation of localization of FOXO transcription factors"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9614657">
<property type="pathway name" value="FOXO-mediated transcription of cell death genes"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9615017">
<property type="pathway name" value="FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9617629">
<property type="pathway name" value="Regulation of FOXO transcriptional activity by acetylation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9617828">
<property type="pathway name" value="FOXO-mediated transcription of cell cycle genes"/>
</dbReference>
<dbReference type="SignaLink" id="Q12778"/>
<dbReference type="SIGNOR" id="Q12778"/>
<dbReference type="BioGRID-ORCS" id="2308">
<property type="hits" value="12 hits in 897 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="FOXO1">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="Q12778"/>
<dbReference type="GeneWiki" id="FOXO1"/>
<dbReference type="GenomeRNAi" id="2308"/>
<dbReference type="Pharos" id="Q12778">
<property type="development level" value="Tbio"/>
</dbReference>
<dbReference type="PRO" id="PR:Q12778"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 13"/>
</dbReference>
<dbReference type="RNAct" id="Q12778">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000150907">
<property type="expression patterns" value="Expressed in female gonad and 257 other tissues"/>
</dbReference>
<dbReference type="Genevisible" id="Q12778">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005739">
<property type="term" value="C:mitochondrion"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000790">
<property type="term" value="C:nuclear chromatin"/>
<property type="evidence" value="ECO:0000247"/>
<property type="project" value="NTNU_SB"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008013">
<property type="term" value="F:beta-catenin binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0003682">
<property type="term" value="F:chromatin binding"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001228">
<property type="term" value="F:DNA-binding transcription activator activity, RNA polymerase II-specific"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003700">
<property type="term" value="F:DNA-binding transcription factor activity"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000981">
<property type="term" value="F:DNA-binding transcription factor activity, RNA polymerase II-specific"/>
<property type="evidence" value="ECO:0000247"/>
<property type="project" value="NTNU_SB"/>
</dbReference>
<dbReference type="GO" id="GO:0001227">
<property type="term" value="F:DNA-binding transcription repressor activity, RNA polymerase II-specific"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0051721">
<property type="term" value="F:protein phosphatase 2A binding"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000978">
<property type="term" value="F:RNA polymerase II cis-regulatory region sequence-specific DNA binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0043565">
<property type="term" value="F:sequence-specific DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001223">
<property type="term" value="F:transcription coactivator binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0008134">
<property type="term" value="F:transcription factor binding"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0031625">
<property type="term" value="F:ubiquitin protein ligase binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006915">
<property type="term" value="P:apoptotic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006914">
<property type="term" value="P:autophagy"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0001568">
<property type="term" value="P:blood vessel development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0001678">
<property type="term" value="P:cellular glucose homeostasis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0070417">
<property type="term" value="P:cellular response to cold"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071549">
<property type="term" value="P:cellular response to dexamethasone stimulus"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0006974">
<property type="term" value="P:cellular response to DNA damage stimulus"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0070301">
<property type="term" value="P:cellular response to hydrogen peroxide"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0071455">
<property type="term" value="P:cellular response to hyperoxia"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032869">
<property type="term" value="P:cellular response to insulin stimulus"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071732">
<property type="term" value="P:cellular response to nitric oxide"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0034599">
<property type="term" value="P:cellular response to oxidative stress"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0009267">
<property type="term" value="P:cellular response to starvation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0019221">
<property type="term" value="P:cytokine-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0070166">
<property type="term" value="P:enamel mineralization"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0031018">
<property type="term" value="P:endocrine pancreas development"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0097009">
<property type="term" value="P:energy homeostasis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045444">
<property type="term" value="P:fat cell differentiation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042593">
<property type="term" value="P:glucose homeostasis"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0008286">
<property type="term" value="P:insulin receptor signaling pathway"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043066">
<property type="term" value="P:negative regulation of apoptotic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0090090">
<property type="term" value="P:negative regulation of canonical Wnt signaling pathway"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:1903243">
<property type="term" value="P:negative regulation of cardiac muscle hypertrophy in response to stress"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045599">
<property type="term" value="P:negative regulation of fat cell differentiation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032873">
<property type="term" value="P:negative regulation of stress-activated MAPK cascade"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0000122">
<property type="term" value="P:negative regulation of transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0045892">
<property type="term" value="P:negative regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0097150">
<property type="term" value="P:neuronal stem cell population maintenance"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0043065">
<property type="term" value="P:positive regulation of apoptotic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0010508">
<property type="term" value="P:positive regulation of autophagy"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045722">
<property type="term" value="P:positive regulation of gluconeogenesis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0045732">
<property type="term" value="P:positive regulation of protein catabolic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045944">
<property type="term" value="P:positive regulation of transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045893">
<property type="term" value="P:positive regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006473">
<property type="term" value="P:protein acetylation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:2000177">
<property type="term" value="P:regulation of neural precursor cell proliferation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:2000377">
<property type="term" value="P:regulation of reactive oxygen species metabolic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0070542">
<property type="term" value="P:response to fatty acid"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1902617">
<property type="term" value="P:response to fluoride"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0001659">
<property type="term" value="P:temperature homeostasis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="CDD" id="cd00059">
<property type="entry name" value="FH"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="DisProt" id="DP01132"/>
<dbReference type="Gene3D" id="1.10.10.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="IDEAL" id="IID00464"/>
<dbReference type="InterPro" id="IPR001766">
<property type="entry name" value="Fork_head_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR032067">
<property type="entry name" value="FOXO-TAD"/>
</dbReference>
<dbReference type="InterPro" id="IPR032068">
<property type="entry name" value="FOXO_KIX-bd"/>
</dbReference>
<dbReference type="InterPro" id="IPR030456">
<property type="entry name" value="TF_fork_head_CS_2"/>
</dbReference>
<dbReference type="InterPro" id="IPR036388">
<property type="entry name" value="WH-like_DNA-bd_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR036390">
<property type="entry name" value="WH_DNA-bd_sf"/>
</dbReference>
<dbReference type="Pfam" id="PF00250">
<property type="entry name" value="Forkhead"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF16676">
<property type="entry name" value="FOXO-TAD"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF16675">
<property type="entry name" value="FOXO_KIX_bdg"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR00053">
<property type="entry name" value="FORKHEAD"/>
</dbReference>
<dbReference type="SMART" id="SM00339">
<property type="entry name" value="FH"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF46785">
<property type="entry name" value="SSF46785"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00658">
<property type="entry name" value="FORK_HEAD_2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50039">
<property type="entry name" value="FORK_HEAD_3"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0010">Activator</keyword>
<keyword id="KW-0053">Apoptosis</keyword>
<keyword id="KW-0072">Autophagy</keyword>
<keyword id="KW-0160">Chromosomal rearrangement</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0221">Differentiation</keyword>
<keyword id="KW-0238">DNA-binding</keyword>
<keyword id="KW-0488">Methylation</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0656">Proto-oncogene</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0804">Transcription</keyword>
<keyword id="KW-0805">Transcription regulation</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="chain" description="Forkhead box protein O1" id="PRO_0000091872">
<location>
<begin position="1"/>
<end position="655"/>
</location>
</feature>
<feature type="DNA-binding region" description="Fork-head" evidence="10">
<location>
<begin position="159"/>
<end position="235"/>
</location>
</feature>
<feature type="region of interest" description="DNA-binding">
<location>
<begin position="211"/>
<end position="218"/>
</location>
</feature>
<feature type="region of interest" description="DNA-binding">
<location>
<begin position="234"/>
<end position="237"/>
</location>
</feature>
<feature type="region of interest" description="Sufficient for interaction with NLK" evidence="6">
<location>
<begin position="283"/>
<end position="563"/>
</location>
</feature>
<feature type="region of interest" description="Required for interaction with RUNX2" evidence="6">
<location>
<begin position="363"/>
<end position="459"/>
</location>
</feature>
<feature type="short sequence motif" description="Nuclear localization signal">
<location>
<begin position="251"/>
<end position="253"/>
</location>
</feature>
<feature type="short sequence motif" description="Required for interaction with SIRT1" evidence="6">
<location>
<begin position="462"/>
<end position="466"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Ala">
<location>
<begin position="91"/>
<end position="102"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Pro">
<location>
<begin position="120"/>
<end position="130"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Ser">
<location>
<begin position="152"/>
<end position="155"/>
</location>
</feature>
<feature type="site" description="DNA-binding">
<location>
<position position="158"/>
</location>
</feature>
<feature type="site" description="DNA-binding">
<location>
<position position="165"/>
</location>
</feature>
<feature type="site" description="DNA-binding">
<location>
<position position="225"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by PKB/AKT1 or PKB/AKT2 and SGK1" evidence="11 13 15">
<location>
<position position="24"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by STK4/MST1" evidence="21 23 26">
<location>
<position position="212"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by STK4/MST1" evidence="21">
<location>
<position position="218"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by STK4/MST1" evidence="21">
<location>
<position position="234"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by STK4/MST1" evidence="21">
<location>
<position position="235"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="9">
<location>
<position position="245"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="9">
<location>
<position position="248"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by CDK1" evidence="20">
<location>
<position position="249"/>
</location>
</feature>
<feature type="modified residue" description="Omega-N-methylarginine; by PRMT1" evidence="9">
<location>
<position position="251"/>
</location>
</feature>
<feature type="modified residue" description="Omega-N-methylarginine; by PRMT1" evidence="9">
<location>
<position position="253"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by PKB/AKT1 and SGK1" evidence="11 12 13 15 27">
<location>
<position position="256"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="24">
<location>
<position position="262"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="24">
<location>
<position position="265"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="24">
<location>
<position position="274"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="3 4 5">
<location>
<position position="287"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="9">
<location>
<position position="298"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by PKB/AKT1" evidence="11 13 15">
<location>
<position position="319"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by CK1 and SGK1" evidence="15">
<location>
<position position="322"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by CK1" evidence="15">
<location>
<position position="325"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by DYRK1A" evidence="14 15">
<location>
<position position="329"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="9">
<location>
<position position="333"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes PKB/AKT1-mediated phosphorylation but does not prevent phosphorylation of Ser-256 or Ser-319. Also inhibits binding of 14-3-3 proteins. Nuclear in unstimulated cells, and little export to cytoplasm on IGF1 stimulation. Inhibits the PKB/AKT1-mediated activity towards other substrates but does not block the IGF1-activated 'T-308' of phosphorylation of PKB/AKT1; when associated with A-256 and A-319. Targeted to the nucleus and enhances transactivation; when associated with A-319." evidence="13 16">
<original>T</original>
<variation>A</variation>
<location>
<position position="24"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes STK4/MST1-mediated phosphorylation." evidence="23">
<original>S</original>
<variation>A</variation>
<location>
<position position="212"/>
</location>
</feature>
<feature type="mutagenesis site" description="Disrupts DNA-binding; when associated with A-248.">
<original>K</original>
<variation>A</variation>
<location>
<position position="245"/>
</location>
</feature>
<feature type="mutagenesis site" description="Disrupts DNA-binding; when associated with A-245.">
<original>K</original>
<variation>A</variation>
<location>
<position position="248"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impaired phosphorylation by CDK1." evidence="20 21">
<original>S</original>
<variation>A</variation>
<location>
<position position="249"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on DNA-binding." evidence="20 21">
<original>S</original>
<variation>E</variation>
<location>
<position position="249"/>
</location>
</feature>
<feature type="mutagenesis site" description="No targeting to the nucleus and disruption of DNA-binding.">
<original>RRR</original>
<variation>SAS</variation>
<location>
<begin position="251"/>
<end position="253"/>
</location>
</feature>
<feature type="mutagenesis site" description="Completely abolishes PKB/AKT1-mediated phosphorylation at all three sites, and inhibits binding of 14-3-3 proteins. Inhibits the PKB/AKT1-mediated activity towards other substrates but does not block the IGF1-activated 'T-308' of phosphorylation of PKB/AKT1; when associated with or without A-24 and A-319. Nuclear in unstimulated cells, and little export to cytoplasm on IGF1 stimulation. Abolishes the ability of IGF1 to suppress transactivation. Prevents T-24 and S-319 phosphorylation. Enhances transactivation; when associated with A-24 and A-319." evidence="13 16 18">
<original>S</original>
<variation>A</variation>
<location>
<position position="256"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces DNA binding, promotes nuclear exclusion and partially promotes T-24 and S-319 phosphorylation. Reduces DNA binding, does not promote nuclear exclusion but reduces transactivation; when associated with A-24 and A-319." evidence="13 16 18">
<original>S</original>
<variation>D</variation>
<location>
<position position="256"/>
</location>
</feature>
<feature type="mutagenesis site" description="Inhibits interaction with ATG7 and FOXO1-acetylation-induced autophagic cell death; when associated with R-265 and R-274.">
<original>K</original>
<variation>R</variation>
<location>
<position position="262"/>
</location>
</feature>
<feature type="mutagenesis site" description="Inhibits interaction with ATG7 and FOXO1-acetylation-induced autophagic cell death; when associated with R-262 and R-274.">
<original>K</original>
<variation>R</variation>
<location>
<position position="265"/>
</location>
</feature>
<feature type="mutagenesis site" description="Inhibits interaction with ATG7 and FOXO1-acetylation-induced autophagic cell death; when associated with R-262 and R-265.">
<original>K</original>
<variation>R</variation>
<location>
<position position="274"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes PKB/AKT1-mediated phosphorylation but does not prevent phosphorylation of Ser-24 or Ser-256. Inhibits the PKB/AKT1-mediated activity towards other substrates but does not block the IGF1-activated 'T-308' of phosphorylation of PKB/AKT1; when associated with A-24 and A-256. Targeted to the nucleus and enhances transactivation; when associated with A-24." evidence="13 16">
<original>S</original>
<variation>A</variation>
<location>
<position position="319"/>
</location>
</feature>
<feature type="mutagenesis site" description="Targeted to the nucleus and enhances transactivation." evidence="14">
<original>S</original>
<variation>A</variation>
<location>
<position position="329"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAA03629." ref="1" evidence="29">
<original>L</original>
<variation>V</variation>
<location>
<position position="131"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 5; AAH70065." ref="5" evidence="29">
<original>V</original>
<variation>M</variation>
<location>
<position position="343"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="156"/>
<end position="158"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="165"/>
<end position="175"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="176"/>
<end position="181"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="183"/>
<end position="193"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="195"/>
<end position="197"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="203"/>
<end position="219"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="223"/>
<end position="226"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="230"/>
<end position="232"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="236"/>
<end position="239"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3CO6"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5DUI"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18669648"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="20068231"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="21406692"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000250"/>
<evidence key="7" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="A4L7N3"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="G3V7R4"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q9R1E0"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00089"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10358075"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10358076"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11237865"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11311120"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11980723"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12228231"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15220471"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15668399"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15890677"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18356527"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18786403"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18951090"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19221179"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20543840"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20668652"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21245099"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="31063815"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9479491"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000305"/>
<sequence length="655" mass="69662" checksum="6DEF6C994BDFDBAB" modified="2006-10-17" version="2">MAEAPQVVEIDPDFEPLPRPRSCTWPLPRPEFSQSNSATSSPAPSGSAAANPDAAAGLPSASAAAVSADFMSNLSLLEESEDFPQAPGSVAAAVAAAAAAAATGGLCGDFQGPEAGCLHPAPPQPPPPGPLSQHPPVPPAAAGPLAGQPRKSSSSRRNAWGNLSYADLITKAIESSAEKRLTLSQIYEWMVKSVPYFKDKGDSNSSAGWKNSIRHNLSLHSKFIRVQNEGTGKSSWWMLNPEGGKSGKSPRRRAASMDNNSKFAKSRSRAAKKKASLQSGQEGAGDSPGSQFSKWPASPGSHSNDDFDNWSTFRPRTSSNASTISGRLSPIMTEQDDLGEGDVHSMVYPPSAAKMASTLPSLSEISNPENMENLLDNLNLLSSPTSLTVSTQSSPGTMMQQTPCYSFAPPNTSLNSPSPNYQKYTYGQSSMSPLPQMPIQTLQDNKSSYGGMSQYNCAPGLLKELLTSDSPPHNDIMTPVDPGVAQPNSRVLGQNVMMGPNSVMSTYGSQASHNKMMNPSSHTHPGHAQQTSAVNGRPLPHTVSTMPHTSGMNRLTQVKTPVQVPLPHPMQMSALGGYSSVSSCNGYGRMGLLHQEKLPSDLDGMFIERLDCDMESIIRNDLMDGDTLDFNFDNVLPNQSFPHSVKTTTHSWVSG</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

